{"id":397630,"date":"2020-12-10T12:04:10","date_gmt":"2020-12-10T17:04:10","guid":{"rendered":"http:\/\/www.marketnewsdesk.com\/?p=397630"},"modified":"2020-12-10T12:04:10","modified_gmt":"2020-12-10T17:04:10","slug":"pharmacy-groups-react-to-supreme-court-ruling-on-state-regulation-of-controversial-pbms","status":"publish","type":"post","link":"https:\/\/www.marketnewsdesk.com\/index.php\/pharmacy-groups-react-to-supreme-court-ruling-on-state-regulation-of-controversial-pbms\/","title":{"rendered":"Pharmacy Groups React to Supreme Court Ruling on State Regulation of Controversial PBMs"},"content":{"rendered":"<h2>\nLandmark Decision Validates Years-Long Fight to Rein in Abusive Power of PBMs<br \/>\n<\/h2>\n<div class=\"mw_release\">\n<p>ALEXANDRIA, Va., Dec.  10, 2020  (GLOBE NEWSWIRE) &#8212; Today, the Supreme Court of the United States\u00a0issued its landmark ruling in <a href=\"https:\/\/www.globenewswire.com\/Tracker?data=yNmaK6SXEtgbm3R_9rr71nDki0QT4ynKy8CZh4HL8AnASAxcacC5kvfb5wjKWcY6mf98weQb4BCPyUGbnqayg7LmirCuZMarfKcmK8L_jchkMndVyu7bbsHGxBS7NuL8Xr5tdOHA7JmFdT0o_qfn60CLsrQTa2J9D14gVRn7od7ZFJwZfY0AZVNuUSpe_QtZ\" rel=\"nofollow noopener noreferrer\" target=\"_blank\"><i>Rutledge v. Pharmaceutical Care Management Association (PCMA)<\/i><\/a><i>, <\/i>determining whether community pharmacies\u202fare protected\u202ffrom abusive payment practices.<\/p>\n<p>The unanimous (8 to 0) decision ruled in favor of the interests of patients and community pharmacies, who have been fighting for years to regulate pharmacy benefit managers (PBMs), the controversial middlemen that manage prescription drug benefits for health insurers, Medicare Part D drug plans, and large employers. With this ruling, states will have greater authority to protect their local businesses and their patients from PBM overreach.<\/p>\n<p>\u201cThis is a historic victory for independent pharmacies and their patients. And it confirms the rights of states to enact reasonable regulations in the name of fair competition and public health,\u201d <b>said<\/b><b>National Community Pharmacists Association CEO B. Douglas Hoey, pharmacist, MBA<\/b>.<\/p>\n<p>\u201cThis is a great day for pharmacists and their patients,\u201d said <b>Scott J. Knoer, executive vice president and CEO of the American Pharmacists Association<\/b>. \u201cFor years, PBMs have threatened the sacrosanct relationship between pharmacists and their patients and have never been forced to answer to any authority for their actions. This opinion redresses that imbalance and returns the power to protect the interests of patients to the states and other local authorities, where it belongs.\u201d<\/p>\n<p>\u201cWe\u2019re excited to see a unanimous decision from the Court on this case \u2013 it\u2019s truly a best case scenario for patients, pharmacists, and pharmacies,\u201d said <b>Rebecca Snead, RPh, NASPA\u00a0executive vice president and CEO.<\/b> \u201cNow, it\u2019s time to get to work to make sure states have appropriate PBM regulations in place, and continue to work with our members of Congress to do the same for the federal programs.\u201d<\/p>\n<p>\u201cToday, Arkansas pharmacists join their colleagues across the country to celebrate a triumphant victory years in the making,\u201d said <b>Arkansas Pharmacists Association CEO John Vinson<\/b>. \u201cThe Supreme Court\u2019s ruling means that states can finally protect our patients who receive their pharmacy benefits through their employers. This win should increase drug pricing transparency, increase pharmacy access for patients, improve freedom of choice, and improve the healthcare for our citizens both during and after the pandemic.\u201d<\/p>\n<p>At issue was the extent to which the federal Employee Retirement Income Security Act of 1974 (ERISA), which regulates private employee benefit plans, preempts the states from regulating the amount that PBMs pay pharmacies to dispense prescription drugs that are covered by an employer-sponsored health plan.<\/p>\n<p>\n        <u>Background: <\/u>\n      <\/p>\n<p>In 2015, Arkansas passed a law\u00a0prohibiting\u00a0PBMs\u00a0from reimbursing local pharmacies at a lower rate than what the pharmacies pay to fill prescriptions. Before the bill was enacted, PBMs were found to reimburse pharmacies at less than a pharmacy\u2019s cost to acquire a drug. This and other pressures have contributed to more than 16 percent of rural independent pharmacies across the country closing their doors in recent years. In Arkansas, nearly 13 percent of the independent pharmacies closed between 2006 and 2014 alone. The PBM lobby, PCMA, challenged the law in court, which is when the\u00a0pharmacy groups\u00a0joined efforts\u00a0to ensure the 2015 law stands. NCPA,\u00a0APA,\u00a0APhA, NASPA, and all state pharmacy associations\u00a0jointly commissioned an amicus brief to support Arkansas Attorney General Leslie Rutledge&#8217;s appeal to allow the implementation of the 2015 legislation\u00a0that prohibited PBMs from paying pharmacies below cost and allowed pharmacies to refuse to dispense below cost prescriptions.\u00a0\u00a0<\/p>\n<p align=\"center\"># # #<\/p>\n<p>      <img loading=\"lazy\" decoding=\"async\" class=\"__GNW8366DE3E__IMG\" src=\"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=ODEwMDM3MiMzODY2NDEwIzIxMjU3NzA=\" width=\"1\" height=\"1\" \/><br \/>\n      <br \/>\n      <img loading=\"lazy\" decoding=\"async\" class=\"__GNW8366DE3E__IMG\" src=\"https:\/\/ml.globenewswire.com\/release\/track\/0afbf447-6559-4ddc-a2a8-7468670333c0\" width=\"1\" height=\"1\" \/>\n    <\/div>\n<div class=\"mw_contactinfo\">\n<pre>Andie Pivarunas\r\nNational Community Pharmacists Association\r\n703-600-1174\r\nandrea.pivarunas@ncpanet.org\r\n<\/pre>\n<\/p><\/div>\n","protected":false},"excerpt":{"rendered":"<p>Landmark Decision Validates Years-Long Fight to Rein in Abusive Power of PBMs ALEXANDRIA, Va., Dec. 10, 2020 (GLOBE NEWSWIRE) &#8212; Today, the Supreme Court of the United States\u00a0issued its landmark ruling in Rutledge v. Pharmaceutical Care Management Association (PCMA), determining whether community pharmacies\u202fare protected\u202ffrom abusive payment practices. The unanimous (8 to 0) decision ruled in favor of the interests of patients and community pharmacies, who have been fighting for years to regulate pharmacy benefit managers (PBMs), the controversial middlemen that manage prescription drug benefits for health insurers, Medicare Part D drug plans, and large employers. With this ruling, states will have greater authority to protect their local businesses and their patients from PBM overreach. \u201cThis is a historic victory for &hellip; <\/p>\n<p class=\"link-more\"><a href=\"https:\/\/www.marketnewsdesk.com\/index.php\/pharmacy-groups-react-to-supreme-court-ruling-on-state-regulation-of-controversial-pbms\/\" class=\"more-link\">Continue reading<span class=\"screen-reader-text\"> &#8220;Pharmacy Groups React to Supreme Court Ruling on State Regulation of Controversial PBMs&#8221;<\/span><\/a><\/p>\n","protected":false},"author":2,"featured_media":0,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[],"tags":[],"class_list":["post-397630","post","type-post","status-publish","format-standard","hentry"],"yoast_head":"<!-- This site is optimized with the Yoast SEO plugin v27.4 - https:\/\/yoast.com\/product\/yoast-seo-wordpress\/ -->\n<title>Pharmacy Groups React to Supreme Court Ruling on State Regulation of Controversial PBMs - Market Newsdesk<\/title>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/www.marketnewsdesk.com\/index.php\/pharmacy-groups-react-to-supreme-court-ruling-on-state-regulation-of-controversial-pbms\/\" \/>\n<meta property=\"og:locale\" content=\"en_US\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"Pharmacy Groups React to Supreme Court Ruling on State Regulation of Controversial PBMs - Market Newsdesk\" \/>\n<meta property=\"og:description\" content=\"Landmark Decision Validates Years-Long Fight to Rein in Abusive Power of PBMs ALEXANDRIA, Va., Dec. 10, 2020 (GLOBE NEWSWIRE) &#8212; Today, the Supreme Court of the United States\u00a0issued its landmark ruling in Rutledge v. Pharmaceutical Care Management Association (PCMA), determining whether community pharmacies\u202fare protected\u202ffrom abusive payment practices. The unanimous (8 to 0) decision ruled in favor of the interests of patients and community pharmacies, who have been fighting for years to regulate pharmacy benefit managers (PBMs), the controversial middlemen that manage prescription drug benefits for health insurers, Medicare Part D drug plans, and large employers. With this ruling, states will have greater authority to protect their local businesses and their patients from PBM overreach. \u201cThis is a historic victory for &hellip; Continue reading &quot;Pharmacy Groups React to Supreme Court Ruling on State Regulation of Controversial PBMs&quot;\" \/>\n<meta property=\"og:url\" content=\"https:\/\/www.marketnewsdesk.com\/index.php\/pharmacy-groups-react-to-supreme-court-ruling-on-state-regulation-of-controversial-pbms\/\" \/>\n<meta property=\"og:site_name\" content=\"Market Newsdesk\" \/>\n<meta property=\"article:published_time\" content=\"2020-12-10T17:04:10+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=ODEwMDM3MiMzODY2NDEwIzIxMjU3NzA=\" \/>\n<meta name=\"author\" content=\"Newsdesk\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:label1\" content=\"Written by\" \/>\n\t<meta name=\"twitter:data1\" content=\"Newsdesk\" \/>\n\t<meta name=\"twitter:label2\" content=\"Est. reading time\" \/>\n\t<meta name=\"twitter:data2\" content=\"3 minutes\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\\\/\\\/schema.org\",\"@graph\":[{\"@type\":\"Article\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/pharmacy-groups-react-to-supreme-court-ruling-on-state-regulation-of-controversial-pbms\\\/#article\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/pharmacy-groups-react-to-supreme-court-ruling-on-state-regulation-of-controversial-pbms\\\/\"},\"author\":{\"name\":\"Newsdesk\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#\\\/schema\\\/person\\\/482f27a394d4fda80ecb5499e519d979\"},\"headline\":\"Pharmacy Groups React to Supreme Court Ruling on State Regulation of Controversial PBMs\",\"datePublished\":\"2020-12-10T17:04:10+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/pharmacy-groups-react-to-supreme-court-ruling-on-state-regulation-of-controversial-pbms\\\/\"},\"wordCount\":584,\"image\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/pharmacy-groups-react-to-supreme-court-ruling-on-state-regulation-of-controversial-pbms\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/www.globenewswire.com\\\/newsroom\\\/ti?nf=ODEwMDM3MiMzODY2NDEwIzIxMjU3NzA=\",\"inLanguage\":\"en-US\"},{\"@type\":\"WebPage\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/pharmacy-groups-react-to-supreme-court-ruling-on-state-regulation-of-controversial-pbms\\\/\",\"url\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/pharmacy-groups-react-to-supreme-court-ruling-on-state-regulation-of-controversial-pbms\\\/\",\"name\":\"Pharmacy Groups React to Supreme Court Ruling on State Regulation of Controversial PBMs - Market Newsdesk\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/pharmacy-groups-react-to-supreme-court-ruling-on-state-regulation-of-controversial-pbms\\\/#primaryimage\"},\"image\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/pharmacy-groups-react-to-supreme-court-ruling-on-state-regulation-of-controversial-pbms\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/www.globenewswire.com\\\/newsroom\\\/ti?nf=ODEwMDM3MiMzODY2NDEwIzIxMjU3NzA=\",\"datePublished\":\"2020-12-10T17:04:10+00:00\",\"author\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#\\\/schema\\\/person\\\/482f27a394d4fda80ecb5499e519d979\"},\"breadcrumb\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/pharmacy-groups-react-to-supreme-court-ruling-on-state-regulation-of-controversial-pbms\\\/#breadcrumb\"},\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/pharmacy-groups-react-to-supreme-court-ruling-on-state-regulation-of-controversial-pbms\\\/\"]}]},{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/pharmacy-groups-react-to-supreme-court-ruling-on-state-regulation-of-controversial-pbms\\\/#primaryimage\",\"url\":\"https:\\\/\\\/www.globenewswire.com\\\/newsroom\\\/ti?nf=ODEwMDM3MiMzODY2NDEwIzIxMjU3NzA=\",\"contentUrl\":\"https:\\\/\\\/www.globenewswire.com\\\/newsroom\\\/ti?nf=ODEwMDM3MiMzODY2NDEwIzIxMjU3NzA=\"},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/pharmacy-groups-react-to-supreme-court-ruling-on-state-regulation-of-controversial-pbms\\\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Home\",\"item\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"Pharmacy Groups React to Supreme Court Ruling on State Regulation of Controversial PBMs\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#website\",\"url\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/\",\"name\":\"Market Newsdesk\",\"description\":\"Latest Business News in Real Time\",\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"en-US\"},{\"@type\":\"Person\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#\\\/schema\\\/person\\\/482f27a394d4fda80ecb5499e519d979\",\"name\":\"Newsdesk\",\"image\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g\",\"url\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g\",\"contentUrl\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g\",\"caption\":\"Newsdesk\"},\"url\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/author\\\/newsdesk\\\/\"}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"Pharmacy Groups React to Supreme Court Ruling on State Regulation of Controversial PBMs - Market Newsdesk","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/www.marketnewsdesk.com\/index.php\/pharmacy-groups-react-to-supreme-court-ruling-on-state-regulation-of-controversial-pbms\/","og_locale":"en_US","og_type":"article","og_title":"Pharmacy Groups React to Supreme Court Ruling on State Regulation of Controversial PBMs - Market Newsdesk","og_description":"Landmark Decision Validates Years-Long Fight to Rein in Abusive Power of PBMs ALEXANDRIA, Va., Dec. 10, 2020 (GLOBE NEWSWIRE) &#8212; Today, the Supreme Court of the United States\u00a0issued its landmark ruling in Rutledge v. Pharmaceutical Care Management Association (PCMA), determining whether community pharmacies\u202fare protected\u202ffrom abusive payment practices. The unanimous (8 to 0) decision ruled in favor of the interests of patients and community pharmacies, who have been fighting for years to regulate pharmacy benefit managers (PBMs), the controversial middlemen that manage prescription drug benefits for health insurers, Medicare Part D drug plans, and large employers. With this ruling, states will have greater authority to protect their local businesses and their patients from PBM overreach. \u201cThis is a historic victory for &hellip; Continue reading \"Pharmacy Groups React to Supreme Court Ruling on State Regulation of Controversial PBMs\"","og_url":"https:\/\/www.marketnewsdesk.com\/index.php\/pharmacy-groups-react-to-supreme-court-ruling-on-state-regulation-of-controversial-pbms\/","og_site_name":"Market Newsdesk","article_published_time":"2020-12-10T17:04:10+00:00","og_image":[{"url":"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=ODEwMDM3MiMzODY2NDEwIzIxMjU3NzA=","type":"","width":"","height":""}],"author":"Newsdesk","twitter_card":"summary_large_image","twitter_misc":{"Written by":"Newsdesk","Est. reading time":"3 minutes"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/pharmacy-groups-react-to-supreme-court-ruling-on-state-regulation-of-controversial-pbms\/#article","isPartOf":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/pharmacy-groups-react-to-supreme-court-ruling-on-state-regulation-of-controversial-pbms\/"},"author":{"name":"Newsdesk","@id":"https:\/\/www.marketnewsdesk.com\/#\/schema\/person\/482f27a394d4fda80ecb5499e519d979"},"headline":"Pharmacy Groups React to Supreme Court Ruling on State Regulation of Controversial PBMs","datePublished":"2020-12-10T17:04:10+00:00","mainEntityOfPage":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/pharmacy-groups-react-to-supreme-court-ruling-on-state-regulation-of-controversial-pbms\/"},"wordCount":584,"image":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/pharmacy-groups-react-to-supreme-court-ruling-on-state-regulation-of-controversial-pbms\/#primaryimage"},"thumbnailUrl":"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=ODEwMDM3MiMzODY2NDEwIzIxMjU3NzA=","inLanguage":"en-US"},{"@type":"WebPage","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/pharmacy-groups-react-to-supreme-court-ruling-on-state-regulation-of-controversial-pbms\/","url":"https:\/\/www.marketnewsdesk.com\/index.php\/pharmacy-groups-react-to-supreme-court-ruling-on-state-regulation-of-controversial-pbms\/","name":"Pharmacy Groups React to Supreme Court Ruling on State Regulation of Controversial PBMs - Market Newsdesk","isPartOf":{"@id":"https:\/\/www.marketnewsdesk.com\/#website"},"primaryImageOfPage":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/pharmacy-groups-react-to-supreme-court-ruling-on-state-regulation-of-controversial-pbms\/#primaryimage"},"image":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/pharmacy-groups-react-to-supreme-court-ruling-on-state-regulation-of-controversial-pbms\/#primaryimage"},"thumbnailUrl":"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=ODEwMDM3MiMzODY2NDEwIzIxMjU3NzA=","datePublished":"2020-12-10T17:04:10+00:00","author":{"@id":"https:\/\/www.marketnewsdesk.com\/#\/schema\/person\/482f27a394d4fda80ecb5499e519d979"},"breadcrumb":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/pharmacy-groups-react-to-supreme-court-ruling-on-state-regulation-of-controversial-pbms\/#breadcrumb"},"inLanguage":"en-US","potentialAction":[{"@type":"ReadAction","target":["https:\/\/www.marketnewsdesk.com\/index.php\/pharmacy-groups-react-to-supreme-court-ruling-on-state-regulation-of-controversial-pbms\/"]}]},{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/pharmacy-groups-react-to-supreme-court-ruling-on-state-regulation-of-controversial-pbms\/#primaryimage","url":"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=ODEwMDM3MiMzODY2NDEwIzIxMjU3NzA=","contentUrl":"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=ODEwMDM3MiMzODY2NDEwIzIxMjU3NzA="},{"@type":"BreadcrumbList","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/pharmacy-groups-react-to-supreme-court-ruling-on-state-regulation-of-controversial-pbms\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Home","item":"https:\/\/www.marketnewsdesk.com\/"},{"@type":"ListItem","position":2,"name":"Pharmacy Groups React to Supreme Court Ruling on State Regulation of Controversial PBMs"}]},{"@type":"WebSite","@id":"https:\/\/www.marketnewsdesk.com\/#website","url":"https:\/\/www.marketnewsdesk.com\/","name":"Market Newsdesk","description":"Latest Business News in Real Time","potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/www.marketnewsdesk.com\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"en-US"},{"@type":"Person","@id":"https:\/\/www.marketnewsdesk.com\/#\/schema\/person\/482f27a394d4fda80ecb5499e519d979","name":"Newsdesk","image":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/secure.gravatar.com\/avatar\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g","url":"https:\/\/secure.gravatar.com\/avatar\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g","contentUrl":"https:\/\/secure.gravatar.com\/avatar\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g","caption":"Newsdesk"},"url":"https:\/\/www.marketnewsdesk.com\/index.php\/author\/newsdesk\/"}]}},"_links":{"self":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/posts\/397630","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/users\/2"}],"replies":[{"embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/comments?post=397630"}],"version-history":[{"count":0,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/posts\/397630\/revisions"}],"wp:attachment":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/media?parent=397630"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/categories?post=397630"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/tags?post=397630"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}